1 results match your criteria: "University Hospital in Martin and Jessenius Medical Faculty of Comenius University[Affiliation]"
Effect of Paricalcitol on Bone Density After Kidney Transplantation: Analysis of 2 Transplant Centers.
Iran J Kidney Dis
November 2017
Surgery Clinic and Transplantation Center, University Hospital in Martin and Jessenius Medical Faculty of Comenius University, Bratislava, Slovakia.
Introduction: The Kidney Disease: Improving Global Outcomes Clinical Practice Guidelines on the management of bone disease in patients with chronic kidney disease recommend periodic measurement of serum calcium, phosphorus, vitamin D, and parathyroid hormone levels after kidney transplantation, with the frequencies that will vary according to the severity of bone disease and graft function. Paricalcitol, a selective vitamin D receptor activator, is indicated in the prevention and treatment of secondary hyperparathyroidism.
Materials And Methods: We retrospectively evaluated the effect of treatment with paricalcitol among our kidney transplant recipients.